vs

Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Alignment Healthcare, Inc. (ALHC). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $821.5M, roughly 1.2× Acadia Healthcare Company, Inc.). Alignment Healthcare, Inc. runs the higher net margin — -1.1% vs -143.3%, a 142.3% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 6.1%). Alignment Healthcare, Inc. produced more free cash flow last quarter ($-55.4M vs $-179.5M). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs 3.4%).

Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

ACHC vs ALHC — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.2× larger
ALHC
$1.0B
$821.5M
ACHC
Growing faster (revenue YoY)
ALHC
ALHC
+38.3% gap
ALHC
44.4%
6.1%
ACHC
Higher net margin
ALHC
ALHC
142.3% more per $
ALHC
-1.1%
-143.3%
ACHC
More free cash flow
ALHC
ALHC
$124.1M more FCF
ALHC
$-55.4M
$-179.5M
ACHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
3.4%
ACHC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACHC
ACHC
ALHC
ALHC
Revenue
$821.5M
$1.0B
Net Profit
$-1.2B
$-11.0M
Gross Margin
Operating Margin
-142.4%
-1.0%
Net Margin
-143.3%
-1.1%
Revenue YoY
6.1%
44.4%
Net Profit YoY
-3710.4%
64.6%
EPS (diluted)
$-12.98
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACHC
ACHC
ALHC
ALHC
Q4 25
$821.5M
$1.0B
Q3 25
$851.6M
$993.7M
Q2 25
$869.2M
$1.0B
Q1 25
$770.5M
$926.9M
Q4 24
$774.2M
$701.2M
Q3 24
$815.6M
$692.4M
Q2 24
$796.0M
$681.3M
Q1 24
$768.1M
$628.6M
Net Profit
ACHC
ACHC
ALHC
ALHC
Q4 25
$-1.2B
$-11.0M
Q3 25
$36.2M
$3.7M
Q2 25
$30.1M
$15.7M
Q1 25
$8.4M
$-9.1M
Q4 24
$32.6M
$-31.1M
Q3 24
$68.1M
$-26.4M
Q2 24
$78.5M
$-24.0M
Q1 24
$76.4M
$-46.5M
Operating Margin
ACHC
ACHC
ALHC
ALHC
Q4 25
-142.4%
-1.0%
Q3 25
4.7%
0.8%
Q2 25
5.8%
2.2%
Q1 25
1.7%
-0.6%
Q4 24
4.9%
-3.2%
Q3 24
12.1%
-2.8%
Q2 24
13.4%
-2.7%
Q1 24
12.9%
-6.5%
Net Margin
ACHC
ACHC
ALHC
ALHC
Q4 25
-143.3%
-1.1%
Q3 25
4.3%
0.4%
Q2 25
3.5%
1.5%
Q1 25
1.1%
-1.0%
Q4 24
4.2%
-4.4%
Q3 24
8.4%
-3.8%
Q2 24
9.9%
-3.5%
Q1 24
9.9%
-7.4%
EPS (diluted)
ACHC
ACHC
ALHC
ALHC
Q4 25
$-12.98
$-0.04
Q3 25
$0.40
$0.02
Q2 25
$0.33
$0.07
Q1 25
$0.09
$-0.05
Q4 24
$0.36
$-0.15
Q3 24
$0.74
$-0.14
Q2 24
$0.85
$-0.13
Q1 24
$0.83
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACHC
ACHC
ALHC
ALHC
Cash + ST InvestmentsLiquidity on hand
$133.2M
$604.2M
Total DebtLower is stronger
$2.5B
$323.2M
Stockholders' EquityBook value
$1.9B
$179.3M
Total Assets
$5.5B
$1.1B
Debt / EquityLower = less leverage
1.28×
1.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACHC
ACHC
ALHC
ALHC
Q4 25
$133.2M
$604.2M
Q3 25
$118.7M
$644.1M
Q2 25
$131.4M
$503.8M
Q1 25
$91.2M
$479.5M
Q4 24
$76.3M
$470.6M
Q3 24
$82.1M
$381.0M
Q2 24
$77.2M
$363.7M
Q1 24
$77.3M
$301.7M
Total Debt
ACHC
ACHC
ALHC
ALHC
Q4 25
$2.5B
$323.2M
Q3 25
$2.3B
$322.7M
Q2 25
$2.3B
$322.3M
Q1 25
$2.2B
$321.9M
Q4 24
$2.0B
$321.4M
Q3 24
$1.9B
$212.0M
Q2 24
$1.8B
$211.7M
Q1 24
$1.9B
$162.0M
Stockholders' Equity
ACHC
ACHC
ALHC
ALHC
Q4 25
$1.9B
$179.3M
Q3 25
$3.1B
$161.9M
Q2 25
$3.1B
$141.0M
Q1 25
$3.0B
$108.1M
Q4 24
$3.1B
$99.9M
Q3 24
$3.0B
$114.5M
Q2 24
$3.0B
$123.7M
Q1 24
$2.9B
$130.9M
Total Assets
ACHC
ACHC
ALHC
ALHC
Q4 25
$5.5B
$1.1B
Q3 25
$6.4B
$1.1B
Q2 25
$6.3B
$1.0B
Q1 25
$6.1B
$895.6M
Q4 24
$6.0B
$782.1M
Q3 24
$5.9B
$692.3M
Q2 24
$5.7B
$716.3M
Q1 24
$5.5B
$633.2M
Debt / Equity
ACHC
ACHC
ALHC
ALHC
Q4 25
1.28×
1.80×
Q3 25
0.74×
1.99×
Q2 25
0.74×
2.29×
Q1 25
0.72×
2.98×
Q4 24
0.64×
3.22×
Q3 24
0.62×
1.85×
Q2 24
0.62×
1.71×
Q1 24
0.65×
1.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACHC
ACHC
ALHC
ALHC
Operating Cash FlowLast quarter
$-86.3M
$-50.4M
Free Cash FlowOCF − Capex
$-179.5M
$-55.4M
FCF MarginFCF / Revenue
-21.8%
-5.5%
Capex IntensityCapex / Revenue
11.3%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-439.9M
$113.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACHC
ACHC
ALHC
ALHC
Q4 25
$-86.3M
$-50.4M
Q3 25
$73.2M
$144.6M
Q2 25
$133.5M
$29.1M
Q1 25
$11.5M
$16.6M
Q4 24
$116.7M
$-8.7M
Q3 24
$163.1M
$26.2M
Q2 24
$171.1M
$23.5M
Q1 24
$-321.3M
$-6.2M
Free Cash Flow
ACHC
ACHC
ALHC
ALHC
Q4 25
$-179.5M
$-55.4M
Q3 25
$-63.0M
$139.1M
Q2 25
$-34.2M
$21.1M
Q1 25
$-163.2M
$8.4M
Q4 24
$-86.8M
$-18.0M
Q3 24
$-27.1M
$16.9M
Q2 24
$16.9M
$11.8M
Q1 24
$-463.7M
$-17.4M
FCF Margin
ACHC
ACHC
ALHC
ALHC
Q4 25
-21.8%
-5.5%
Q3 25
-7.4%
14.0%
Q2 25
-3.9%
2.1%
Q1 25
-21.2%
0.9%
Q4 24
-11.2%
-2.6%
Q3 24
-3.3%
2.4%
Q2 24
2.1%
1.7%
Q1 24
-60.4%
-2.8%
Capex Intensity
ACHC
ACHC
ALHC
ALHC
Q4 25
11.3%
0.5%
Q3 25
16.0%
0.6%
Q2 25
19.3%
0.8%
Q1 25
22.7%
0.9%
Q4 24
26.3%
1.3%
Q3 24
23.3%
1.3%
Q2 24
19.4%
1.7%
Q1 24
18.5%
1.8%
Cash Conversion
ACHC
ACHC
ALHC
ALHC
Q4 25
Q3 25
2.02×
38.77×
Q2 25
4.43×
1.86×
Q1 25
1.37×
Q4 24
3.58×
Q3 24
2.39×
Q2 24
2.18×
Q1 24
-4.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACHC
ACHC

Acute Inpatient Psychiatric Facilities$451.2M55%
Comprehensive Treatment Centers$144.2M18%
Medicare$113.7M14%
Residential Treatment Centers$89.7M11%
Self Payor$16.1M2%
Other Payor$10.7M1%

ALHC
ALHC

Segment breakdown not available.

Related Comparisons